| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/02/2009 | US20090170951 Phenolic Hydrazone Macrophage Migration Inhibitory Factor Inhibitors |
| 07/02/2009 | US20090170941 Pharmaceutical Compounds |
| 07/02/2009 | US20090170934 Manufacturing process for no-donating compounds such as no-donating diclofenac |
| 07/02/2009 | US20090170911 Novel azole compound |
| 07/02/2009 | US20090170909 N-cyclopropyl-3S-{4-methanesulfonyl-2S-[2,2,2-trifluoro-1S-(4-fluoro-phenyl)-ethylamino]-butyrylamino}-2-oxo-pentanamide; rheumatoid arthritis, multiple sclerosis, myasthenia gravis, psoriasis, pemphigus vulgaris, Graves' disease, myasthenia gravis, systemic lupus erythemotasus, asthma, pain, and atheros |
| 07/02/2009 | US20090170882 Methods and compositions |
| 07/02/2009 | US20090170881 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170877 5,6-Trimethylenepyrimidin-4-one compounds |
| 07/02/2009 | US20090170854 New Use |
| 07/02/2009 | US20090170853 4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent (hepatocellular cancer, colorectal cancer or non-small cell lung cancer) |
| 07/02/2009 | US20090170836 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170821 2-Methylene-(20S,25S)-19,26-Dinor-Vitamin D Analogs |
| 07/02/2009 | US20090170819 (20R)-23,23-Difluoro-2-Methylene-19-Nor-Bishomopregnacalciferol-Vitamin D Analogs |
| 07/02/2009 | US20090170818 Arresting the proliferation of undifferentiated cells and inducing their differentiation; anticancer agents; treating psoriasis, wrinkles, slack skin, dry skin, insufficient sebum secretion, autoimmune disorders, inflammatory diseases, renal osteodystrophy. and obesity; little, if any, calcemic activity |
| 07/02/2009 | US20090170803 Adjunctive treatment of biological diseases |
| 07/02/2009 | US20090170769 Cell surface receptor isoforms and methods of identifying and using the same |
| 07/02/2009 | US20090169614 Methods of suppressing microglial activation and systemic inflammatory responses |
| 07/02/2009 | US20090169584 Treatment of sleep disturbances |
| 07/02/2009 | US20090169555 Administering the kinase to regulate mitogenesis, apoptosis, neuronal development, chemotaxis, angiogenesis or an inflammatory response inclding developmental retardation, excessive apoptosis, cancer, restenosis and diabetic neuropathy; screening for drugs that stimulate or inhibit lipid phosphorylation |
| 07/02/2009 | US20090169543 Method for regulating immune function in primates using the Foxp3 protein |
| 07/02/2009 | CA2710118A1 Sulfamides as zap-70 inhibitors |
| 07/02/2009 | CA2710016A1 Translocator protein ligands |
| 07/02/2009 | CA2709937A1 Halogenated analogues of anti-fibrotic agents |
| 07/02/2009 | CA2709510A1 Bis-(sulfonylamino) derivatives for use in therapy |
| 07/02/2009 | CA2708502A1 Perhydroquinoxaline derivatives |
| 07/02/2009 | CA2704268A1 Receptor targeting ligands |
| 07/01/2009 | EP2075258A1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same |
| 07/01/2009 | EP2075249A2 Indolylmaleimide derivatives |
| 07/01/2009 | EP2074995A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 07/01/2009 | EP2074106A1 Dibenzofuran derivatives as inhibitors of pde-4 and pde-10 |
| 07/01/2009 | EP2074093A2 Matrix metalloproteinase inhibitors |
| 07/01/2009 | EP2074084A1 Compounds which modulate the cb2 receptor |
| 07/01/2009 | EP2074083A1 New sulfonamide derivatives as bradykinin antagonists |
| 07/01/2009 | EP2073830A1 Interferon type i supporting compounds |
| 07/01/2009 | EP2073816A2 Inhibitors of fatty acid amide hydrolase |
| 07/01/2009 | EP2073808A2 New method for the treatment of inflammatory diseases |
| 07/01/2009 | EP2073804A2 Hydroxy-substituted benzoic acid amide compounds for use in therapy |
| 07/01/2009 | EP2073799A2 Novel agents of calcium ion channel modulators |
| 07/01/2009 | EP1756043B1 Ortho substituted aryl or heteroaryl amide compounds |
| 07/01/2009 | EP1740583B1 Oxadiazolone derivatives as ppar delta agonists |
| 07/01/2009 | EP1713439B1 Pharmaceutical preparation for the oral cavity |
| 07/01/2009 | EP1537075B1 Diarylurea derivatives and their use as chloride channel blockers |
| 07/01/2009 | EP1471054B1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/01/2009 | EP1414428B1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 07/01/2009 | EP1312675B1 Protein induced by homogeneous blood transfusion and dna encoding the same |
| 07/01/2009 | CN100506846C Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 07/01/2009 | CN100506831C Phosphonic acid compounds as inhibitors of serine proteases |
| 07/01/2009 | CN100506815C Piperidinyl targeting compounds that selectively bind integrins |
| 07/01/2009 | CN100506802C Formyl peptide-like acceptor-1 regulator and its Preparation and use |
| 07/01/2009 | CN100506791C Pentafluorosulfanylbenzoylguanidines, preparation method, their use as medicaments or diagnostic aids, and medicaments comprising them |
| 07/01/2009 | CN100506277C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 07/01/2009 | CN100506249C Plaster for treating knocks and falls, and osteopathia |
| 07/01/2009 | CN100506234C Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn disease |
| 07/01/2009 | CN100506231C Anti-inflammatory compositions and methods of use |
| 06/30/2009 | US7553971 Aryl aniline β2 adrenergic receptor agonists |
| 06/30/2009 | US7553966 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/30/2009 | US7553918 pH-sensitive polymer |
| 06/30/2009 | US7553877 Use of 2-hydroxy-1,2,3,4,4a,9,10,10a-octahydrophenanthrene compounds glucocorticoid receptor agonists to treat certain inflammatory conditions such as arthritis, asthma |
| 06/30/2009 | US7553868 2-[(Aminocarbonyl)amino]-5-[2-{2-[{N-(2-chlorobenzyl)-N-methyl}amino]ethoxy}phenyl]-thiophene-3-carboxamide; serine/threonine kinase inhibitors; antiinflammatory agents; asthma; rheumatic diseases; antiarthritic agents; multiple sclerosis; chronic obstructive pulmonary disease |
| 06/30/2009 | US7553865 Compounded with glyceryl monostearate, sorbitan monostearate, or stearyl alcohol; excellent use feeling and excellent absorbability, causes no phase separation into an oil layer and an aqueous layer, stability |
| 06/30/2009 | US7553852 Caspase inhibitors and uses thereof |
| 06/30/2009 | US7553492 Gene overexpression/underexpression; antibodies; drug screening; kits |
| 06/30/2009 | US7553483 Chemokine mutants acting as chemokine antagonists |
| 06/30/2009 | CA2307111C Novel pyridazine derivatives and drugs containing the same as the active ingredient |
| 06/25/2009 | WO2009078432A1 1-alkyl-4-amino-1h-pyrazole-3-carboxamide compound |
| 06/25/2009 | WO2009078423A1 Fused tricyclic compound having aldose reductase inhibitory activity |
| 06/25/2009 | WO2009077990A1 Aminotriazole derivatives as alx agonists |
| 06/25/2009 | WO2009077635A2 Anti-inflammatory, anti-edematous and anti-erythematous composition, method for obtaining same and use thereof |
| 06/25/2009 | WO2009077608A1 2 -aminopyrimidine derivatives as histamine h4 antagonists |
| 06/25/2009 | WO2009077559A2 5-oxo-3-pyrrolidinecarboxamide derivatives as p2x7 modulators |
| 06/25/2009 | WO2009077483A1 Antibodies against human nkg2d and uses thereof |
| 06/25/2009 | WO2009077371A1 Tetrazole-substituted arylamide derivatives and their use as p2x3 and/or p2x2/3 purinergic receptor antagonists |
| 06/25/2009 | WO2009077366A1 Triazole-substituted arylamide derivatives and their use as p2x3 and /or p2x2/3 purinergic receptor antagonists |
| 06/25/2009 | WO2009077334A1 Novel imidazo[1,2-a]pyridine and imidazo[1,2-b]pyridazine derivatives |
| 06/25/2009 | WO2009053683A3 Treatment of inflammatory diseases |
| 06/25/2009 | WO2009049961A3 New no-donor aspirin derivatives |
| 06/25/2009 | WO2009048541A3 Compounds and methods for use in treating neoplasia and cancer |
| 06/25/2009 | WO2009023471A3 Compositions comprising a dissociated glucocorticoid receptor agonist for treating or controlling anterior-segment inflammation |
| 06/25/2009 | WO2009020561A3 Compositions and methods of use thereof, for the treatment of oral pain, comprising cloves or extract thereof in combination with a steroid |
| 06/25/2009 | WO2008046084A3 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 06/25/2009 | US20090163599 Mif adsorbant |
| 06/25/2009 | US20090163597 Preparation for Iontophoresis |
| 06/25/2009 | US20090163593 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists; pain, Parkinson's disease, multiple sclerosis, or Huntington's chorea; asthma |
| 06/25/2009 | US20090163591 Use of sugar phosphates, sugar phosphate analogs, amino acids and/or amino acid analogs for modulating the glucolysis-enzyme complex, the malate asparate shuttle and/or the transaminases |
| 06/25/2009 | US20090163590 Process for producing refined avocado oil rich in triglycerides, and oil obtainable by said process |
| 06/25/2009 | US20090163581 Pharmaceutical Products for Treating Neoplastic Disease and Inflammation |
| 06/25/2009 | US20090163562 Oral composition comprising 3-[5-[4-(cyclopentyloxy) -2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6- yl)methoxy]phenyl]propionic acid or salt thereof |
| 06/25/2009 | US20090163556 Glycinamide derivatives as raf-kinase inhbitors |
| 06/25/2009 | US20090163534 Indolizine Derivatives |
| 06/25/2009 | US20090163530 adapted to adhere to and dissolve in a mouth of a consumer include a water soluble film-forming polymer pullulan, antimicrobially effective amounts of essential oils thymol, methyl salicylate, eucalyptol and menthol; for killing plaque-producing germs that cause dental plaque, bad breath, gingivitis |
| 06/25/2009 | US20090163528 Pharmaceutical composition having analgesic effects |
| 06/25/2009 | US20090163508 Amide compound |
| 06/25/2009 | US20090163506 Urea-compounds active as vanilloid receptor antagonists for the treatment of pain |
| 06/25/2009 | US20090163499 Imidazole-substituted arylamides as P2X3 and P2X2/3 antagonists |
| 06/25/2009 | US20090163497 Compounds Useful as Antagonists of CCR2 |
| 06/25/2009 | US20090163495 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 06/25/2009 | US20090163493 cell proliferation, such as cancer, inflammation, and angiogenesis; fungal infections; antimalaria; Heat hock protein 90 (HSP-90) inhibitor |
| 06/25/2009 | US20090163481 Ppar-delta ligands and methods of their use |
| 06/25/2009 | US20090163477 Phthalazinone derivatives |
| 06/25/2009 | US20090163467 New compounds |